Complete Genomics has appointed Mark Sutherland as senior vice president of business development. Among his highest priorities will be working more closely with large pharmaceutical companies and the National Institutes of Health. He will also help the company open satellite genome centers in other countries.
Sutherland comes to Complete Genomics from GenVault, where he held the same position. Prior to that, he was vice president of strategic alliances for the Discovery Systems business unit of GE Healthcare, and before that, vice president of genomics for Amersham Biosciences. Previously, he had various sales and marketing management roles at Molecular Dynamics and Applied Biosystems. Sutherland holds a BS in chemistry from Stanford University.
Shankar Balasubramanian has been named Innovator of the Year by the UK's Biotechnology and Biological Sciences Research Council, in recognition of his work on the sequencing technology that was later commercialized by Solexa (now part of Illumina). He received a £10,000 ($15,000) award. Balasubramanian is a professor at the University of Cambridge and a co-founder of Solexa.